[4-[3-[1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoylamino]-2-(5-methoxy-1-methylpyrazol-3-yl)ethyl]-6-oxo-1H-pyridazin-5-yl]phenyl]carbamic acid

C28H25ClN10O5 — CID 66698609

IUPAC[4-[3-[1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoylamino]-2-(5-methoxy-1-methylpyrazol-3-yl)ethyl]-6-oxo-1H-pyridazin-5-yl]phenyl]carbamic acid
SMILESCOc1cc(CC(NC(=O)C=Cc2cc(Cl)ccc2-n2cnnn2)c2cc(-c3ccc(NC(=O)O)cc3)c(=O)[nH]n2)nn1C
InChIInChI=1S/C28H25ClN10O5/c1-38-26(44-2)13-20(35-38)12-22(23-14-21(27(41)34-33-23)16-3-7-19(8-4-16)31-28(42)43)32-25(40)10-5-17-11-18(29)6-9-24(17)39-15-30-36-37-39/h3-11,13-15,22,31H,12H2,1-2H3,(H,32,40)(H,34,41)(H,42,43)
InChIKeyNMXLQDHPPOZACG-UHFFFAOYSA-N
MW617.03 g/mol
LogP3.01
Rot. Bonds10

About [4-[3-[1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoylamino]-2-(5-methoxy-1-methylpyrazol-3-yl)ethyl]-6-oxo-1H-pyridazin-5-yl]phenyl]carbamic acid

[4-[3-[1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoylamino]-2-(5-methoxy-1-methylpyrazol-3-yl)ethyl]-6-oxo-1H-pyridazin-5-yl]phenyl]carbamic acid (PubChem CID 66698609) has the molecular formula C28H25ClN10O5 and a molecular weight of 617.03 g/mol. Its IUPAC name is [4-[3-[1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoylamino]-2-(5-methoxy-1-methylpyrazol-3-yl)ethyl]-6-oxo-1H-pyridazin-5-yl]phenyl]carbamic acid.

Molecular Properties

Compound Name[4-[3-[1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoylamino]-2-(5-methoxy-1-methylpyrazol-3-yl)ethyl]-6-oxo-1H-pyridazin-5-yl]phenyl]carbamic acid
PubChem CID66698609
Molecular FormulaC28H25ClN10O5
Molecular Weight617.03 g/mol
Exact Mass616.17
IUPAC Name[4-[3-[1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoylamino]-2-(5-methoxy-1-methylpyrazol-3-yl)ethyl]-6-oxo-1H-pyridazin-5-yl]phenyl]carbamic acid
SMILESCOc1cc(CC(NC(=O)C=Cc2cc(Cl)ccc2-n2cnnn2)c2cc(-c3ccc(NC(=O)O)cc3)c(=O)[nH]n2)nn1C
InChIInChI=1S/C28H25ClN10O5/c1-38-26(44-2)13-20(35-38)12-22(23-14-21(27(41)34-33-23)16-3-7-19(8-4-16)31-28(42)43)32-25(40)10-5-17-11-18(29)6-9-24(17)39-15-30-36-37-39/h3-11,13-15,22,31H,12H2,1-2H3,(H,32,40)(H,34,41)(H,42,43)
InChIKeyNMXLQDHPPOZACG-UHFFFAOYSA-N
XLogP3.01
TPSA194.83 Ų
H-Bond Donors4
H-Bond Acceptors11
Rotatable Bonds10
Heavy Atoms44
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500617.03
LogP ≤ 53.01
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1011

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze [4-[3-[1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoylamino]-2-(5-methoxy-1-methylpyrazol-3-yl)ethyl]-6-oxo-1H-pyridazin-5-yl]phenyl]carbamic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [4-[3-[1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoylamino]-2-(5-methoxy-1-methylpyrazol-3-yl)ethyl]-6-oxo-1H-pyridazin-5-yl]phenyl]carbamic acid?
The IUPAC name of [4-[3-[1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoylamino]-2-(5-methoxy-1-methylpyrazol-3-yl)ethyl]-6-oxo-1H-pyridazin-5-yl]phenyl]carbamic acid (CID 66698609) is [4-[3-[1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoylamino]-2-(5-methoxy-1-methylpyrazol-3-yl)ethyl]-6-oxo-1H-pyridazin-5-yl]phenyl]carbamic acid.
What is the SMILES notation for [4-[3-[1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoylamino]-2-(5-methoxy-1-methylpyrazol-3-yl)ethyl]-6-oxo-1H-pyridazin-5-yl]phenyl]carbamic acid?
The canonical SMILES for [4-[3-[1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoylamino]-2-(5-methoxy-1-methylpyrazol-3-yl)ethyl]-6-oxo-1H-pyridazin-5-yl]phenyl]carbamic acid is COc1cc(CC(NC(=O)C=Cc2cc(Cl)ccc2-n2cnnn2)c2cc(-c3ccc(NC(=O)O)cc3)c(=O)[nH]n2)nn1C.
What is the InChIKey of [4-[3-[1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoylamino]-2-(5-methoxy-1-methylpyrazol-3-yl)ethyl]-6-oxo-1H-pyridazin-5-yl]phenyl]carbamic acid?
The InChIKey is NMXLQDHPPOZACG-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H25ClN10O5/c1-38-26(44-2)13-20(35-38)12-22(23-14-21(27(41)34-33-23)16-3-7-19(8-4-16)31-28(42)43)32-25(40)10-5-17-11-18(29)6-9-24(17)39-15-30-36-37-39/h3-11,13-15,22,31H,12H2,1-2H3,(H,32,40)(H,34,41)(H,42,43).
What are the key properties of [4-[3-[1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoylamino]-2-(5-methoxy-1-methylpyrazol-3-yl)ethyl]-6-oxo-1H-pyridazin-5-yl]phenyl]carbamic acid?
[4-[3-[1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoylamino]-2-(5-methoxy-1-methylpyrazol-3-yl)ethyl]-6-oxo-1H-pyridazin-5-yl]phenyl]carbamic acid has a molecular weight of 617.03 g/mol, XLogP of 3.01, 10 rotatable bonds, 4 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for [4-[3-[1-[3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoylamino]-2-(5-methoxy-1-methylpyrazol-3-yl)ethyl]-6-oxo-1H-pyridazin-5-yl]phenyl]carbamic acid is sourced from PubChem (CID 66698609), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).